Iowa Medicaid coverage for Wegovy (Weight Loss)

Requests for weight loss, which is not a covered diagnosis of use, will be denied.

Policy note: Wegovy (semaglutide for weight management) falls under the Anti-Diabetics, Non-Insulin Agents section. The policy explicitly states: 'Requests for weight loss, which is not a covered diagnosis of use, will be denied.' Wegovy is a GLP-1 RA approved solely for weight management; as weight loss is explicitly not covered, Wegovy is not covered. The cv_risk_reduction and mash indications are not addressed by this document.

Policy effective June 1, 2026 · verified June 4, 2026 · source: policy-387.html